Report - Teplizumab treatment of type diabetes 1 · Teplizumab for treatment of type 1 diabetes (Protégé study): 1‐ year ... Use of inhaled insulin, exenatide, or other agents that stimulate

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form